Chyten Brennan J, Patel VV, Anastos K, Hanna DB (2022). Role of gender-affirming hormonal care in HIV care continuum outcomes when comparing transgender women with cisgender sexual minority men. JAIDS 91: 255-260.
Hanna DB, Felsen UR, Anastos K, Bauman LJ, Fiori KP, Ginsberg MS, Watnick D, Chambers EC (2022). Association of unmet social needs with uncontrolled viremia in people with HIV. AIDS Behav 26: 3740-3745.
Hanna DB, Hua S, Gonzalez F, Kershaw KN, Rundle AG, Van Horn LV, Wylie-Rosett J, Gellman MD, Lovasi GS, Kaplan RC, Mossavar-Rahmani Y, Shaw PA (2021). Higher neighborhood population density is associated with lower potassium intake in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Intl J Environ Res Public Health 18: 10716.
El Far M*, Hanna DB*, Durand M, Larouche-Anctil E, Sylla M, Chartrand-Lefebvre C, Cloutier G, Goulet JP, Kassaye S, Karim R, Kizer JR, French AL, Gange SJ, Lazar JM, Hodis HN, Routy J-P, Ancuta P, Chomont N, Landay AL, Kaplan RC, Tremblay CL (2021). Subclinical carotid artery atherosclerosis is associated with increased expression of peripheral blood IL-32 isoforms among women living with HIV. JAIDS 88: 186-191. *Co-first author.
Patel VV, Felsen UR, Fisher M, Fazzari MJ, Ginsberg MS, Beil R, Akiyama MJ, Anastos K, Hanna DB (2021). Clinical outcomes and inflammatory markers by HIV serostatus and viral suppression in a large cohort of patients hospitalized with COVID-19. JAIDS 86: 224-230.
Chyten-Brennan J, Patel VV, Ginsberg MS, Hanna DB (2021). Algorithm to identify transgender and gender nonbinary individuals among people living with HIV performs differently by age and ethnicity. Ann Epidemiol 54: 73-78.
Brusca RM*, Hanna DB*, Wada NI, Blankson JN, Witt MD, Jacobson LP, Kingsley L, Palella FJ, Budoff M, Brown TT, Anastos K, Lazar JM, Mack WJ, Bacchetti P, Tien PC, Golzar Y, Plankey M, Golub E, Kaplan RC, Post WS (2020). Subclinical cardiovascular disease in HIV controller and long-term non-progressor populations. HIV Med 21: 217-227. *Co-first author.
Hanna DB, Ramaswamy C, Kaplan RC, Kizer JR, Daskalakis DC, Anastos K, Braunstein SL (2019). Sex- and poverty-specific patterns in HIV-associated cardiovascular mortality in New York City, 2007-2017. Clin Infect Dis 71: 491-498.
Lin J, Xue X, Anastos K, Cohen MH, Gange SJ, Lazar JM, Liu C, Mack WJ, Tien PC, Tilley C, Hodis HN, Landay AL, Tracy RP, Kaplan RC, Hanna DB (2019). Elevated microparticle tissue factor activity is associated with carotid artery plaque in HIV-infected women. JAIDS 81: 36-43.
Hanna DB, Lazar JM, Avadhani S, Kaplan RC, Anastos K, Gange SJ, Holman S, Minkoff HL, Kizer JR (2019). Assessment of different classification schemes for identification of diastolic dysfunction in the Women’s Interagency HIV Study. J Am Soc Echocardiography 32: 547-548.
Hanna DB, Moon J-Y, Haberlen SA, French AL, Palella FJ, Gange SJ, Witt MD, Kassaye S, Lazar JM, Tien PC, Feinstein MJ, Kingsley LA, Post WS, Kaplan RC, Hodis HN, Anastos K (2018). Carotid artery atherosclerosis is associated with mortality in HIV-positive women and men. AIDS 32: 2393-2403.
Ross J, Cunningham CO, Hanna DB (2018). HIV outcomes among migrants living in high-income countries: a review of recent evidence. Curr Opin Inf Diseases 31: 25-32.
Ross J, Felsen UR, Cunningham CO, Patel VV, Hanna DB (2017). Outcomes along the HIV care continuum among undocumented immigrants in clinical care. AIDS Res Hum Retroviruses 33: 1038-1044.
Hanna DB, Xu S, Melamed ML, Gonzalez F, Allison MA, Blisker MS, Hurwitz BE, Kansal MM, Schneiderman N, Shah SJ, Kaplan RC, Rodriguez CJ, Kizer JR (2017). Association of albuminuria with cardiac dysfunction in U.S. Hispanics/Latinos. Am J Cardiol 119: 2073-2080.
Hanna DB, Lin J, Post WS, Hodis HN, Xue X, Anastos K, Cohen MH, Gange SJ, Haberlen SA, Heath SL, Lazar JM, Liu C, Mack WJ, Ofotokun I, Palella FJ, Tien PC, Witt MD, Landay AL, Kingsley LA, Tracy RP, Kaplan RC (2017). Association of macrophage inflammation biomarkers with progression of subclinical carotid atherosclerosis in HIV-infected women and men [with editorial commentary]. J Infect Dis 215: 1352-1361.
Hanna DB, Jung M, Xue X, Anastos K, Cocohoba JM, Cohen MH, Golub ET, Hessol NA, Levine AM, Wilson TE, Young MA, Kaplan RC (2016). Trends in non-lipid cardiovascular disease risk factor management in the Women’s Interagency HIV Study and association with adherence to antiretroviral therapy. AIDS Patient Care STDs 30: 445-454.
Hanna DB, Ramaswamy C, Kaplan RC, Kizer JR, Anastos K, Daskalakis D, Zimmerman R, Braunstein SL (2016). Trends in cardiovascular disease mortality among persons with HIV in New York City, 2001-2012. Clin Infect Dis 63: 1122-1129.
Hanna DB, Guo M, Bůžková P, Miller TL, Post WS, Stein JH, Currier JS, Kronmal RA, Freiberg MS, Bennett SN, Shikuma CM, Anastos K, Li Y, Tracy RP, Hodis HN, Delaney JA, Kaplan RC (2016). HIV infection and carotid artery intima-media thickness: Pooled analyses across five cohorts of the NHLBI HIV-CVD Collaborative. Clin Infect Dis 63: 249-256.
Hanna DB, Felsen UR, Ginsberg MS, Zingman BS, Beil RS, Futterman DC, Strickler HD, Anastos K (2016). Increased antiretroviral therapy use and virologic suppression in the Bronx in the context of multiple HIV prevention strategies. AIDS Res Hum Retroviruses 32: 955-963.
Hanna DB, Post WS, Deal JA, Hodis HN, Jacobson LP, Mack WJ, Anastos K, Gange SJ, Landay AL, Lazar JM, Palella FJ, Tien PC, Witt MD, Xue X, Young MA, Kaplan RC, Kingsley LA (2015). HIV infection is associated with progression of subclinical carotid atherosclerosis. Clin Infect Dis 61: 640-650.
Shaked I*, Hanna DB*, Gleißner C, Marsh B, Plants J, Tracy D, Anastos K, Cohen M, Golub ET, Karim R, Lazar J, Prasad V, Tien PC, Young MA, Landay AL, Kaplan RC, Ley K (2014). Macrophage inflammatory markers are associated with subclinical carotid artery disease in women with HIV or HCV infection. Arterioscler Thromb Vasc Biol 34: 1085-1092. *Co-first author.
Hanna DB, Hessol NA, Golub ET, Cocohoba JM, Cohen MH, Levine AM, Wilson TE, Young M, Anastos K, Kaplan RC (2014). Increase in single-tablet regimen use and associated improvements in adherence-related outcomes in HIV-infected women. J Acquir Immune Defic Syndr 65: 587-596.
Hanna DB, Buchacz K, Gebo KA, Hessol NA, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, Korthuis PT, Moore RD, Napravnik S, Patel P, Silverberg MJ, Sterling TR, Willig JH, Collier A, Samji H, Thorne JE, Althoff KN, Martin JN, Rodriguez B, Stuart EA, Gange SJ for the NA-ACCORD (2013). Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009. PLOS ONE 8: e78952.
Hanna DB, Buchacz K, Gebo KA, Hessol NA, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, Korthuis PT, Moore RD, Napravnik S, Patel P, Silverberg MJ, Sterling TR, Willig JH, Lau B, Althoff KN, Crane HM, Collier AC, Samji H, Thorne JE, Gill MJ, Klein MB, Martin JN, Rodriguez B, Rourke SB, Gange SJ for the NA-ACCORD (2013). Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. Clin Infect Dis 56: 1174-1182.
Hanna DB, Selik RM, Tang T, Gange SJ (2012). Disparities among U.S. states in HIV-related mortality in persons with HIV infection, 2001-2007. AIDS 26: 95-103.